Sökresultat - Jean‐Paul Guastalla
- Visas 1 - 13 av 13 resultat
-
1
-
2
-
3
-
4
Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors av G. Catimel, G G Chabot, Jean‐Paul Guastalla, A Dumortier, Claudia Côté, Caroline Engel, Alain Gouyette, A. Mathieu-Boué, M. Mahjoubi, M. Clavel
Publicerad 1995Artigo -
5
HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients av Marianne Tuefferd, Jérôme Couturier, Frédérique Penault–Llorca, Anne Vincent‐Salomon, Philippe Broët, Jean‐Paul Guastalla, Djelila Allouache, M. Combe, B. Weber, Éric Pujade-Lauraine, Sophie Camilleri‐Bröet
Publicerad 2007Artigo -
6
Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer av Isabelle Treilleux, Jean‐Yves Blay, Nathalie Bendriss‐Vermare, Isabelle Ray‐Coquard, Thomas Bachelot, Jean‐Paul Guastalla, Alain Brémond, Sophie Goddard, Jean‐Jacques Pin, Clarisse Barthélemy‐Dubois, Serge Lebecque
Publicerad 2004Artigo -
7
Disease-Free Survival Advantage of Weekly Epirubicin Plus Tamoxifen Versus Tamoxifen Alone As Adjuvant Treatment of Operable, Node-Positive, Elderly Breast Cancer Patients: 6-Year... av P. Fargeot, Jacques Bonneterre, Henri Roché, Alain Lortholary, Mario Campone, Isabelle Van Praagh, Alain Monnier, Moïse Namer, S Schraub, Jean-Claude Barats, Jean‐Paul Guastalla, Marie-Josèphe Goudier, Isabelle Chapelle-Marcillac
Publicerad 2004Artigo -
8
Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study av Jean-Marc Extra, Eric C. Antoine, Anne Vincent‐Salomon, T. Delozier, Pierre Kerbrat, Anne Béthune-Volters, Jean‐Paul Guastalla, M. Spielmann, L. Mauriac, Jean-Louis Misset, Daniel Serin, Mario Campone, Christophe Hébert, C Remblier, Loïc Bergougnoux, Frank Campana, Moïse Namer
Publicerad 2010Artigo -
9
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas av Isabelle Ray‐Coquard, Claire Cropet, M. van Glabbeke, Catherine Sebban, Axel Le Cesne, Ian Judson, Olivier Trédan, Jaap Verweij, Pierre Biron, Sana Intidhar Labidi‐Galy, Jean‐Paul Guastalla, Thomas Bachelot, David Pérol, Sylvie Chabaud, Pancras C.W. Hogendoorn, Philippe A. Cassier, Armelle Dufresne, Jean‐Yves Blay
Publicerad 2009Artigo -
10
Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized... av Véronique Dièras, Hans Wildiers, Jacek Jassem, Luc Dirix, Jean‐Paul Guastalla, Petri Bono, Sara A. Hurvitz, Anthony Gonçalvès, Gilles Romieu, Steven Limentani, Guy Jérusalem, K C Lakshmaiah, Henri Roché, Pedro Sánchez‐Rovira, Tadeusz Pieńkowski, Miguel Ángel Seguí, Li Ai, Yu‐Nien Sun, Cheryl A. Pickett, Dennis J. Slamon
Publicerad 2015Artigo -
11
Adjuvant Docetaxel for Node-Positive Breast Cancer av Miguel Martín, Tadeusz Pieńkowski, John R. Mackey, Marek Pawlicki, Jean‐Paul Guastalla, Charles H. Weaver, Eva Tomiak, Taher Al‐Tweigeri, Linnea Chap, É Juhos, R. Guévin, Anthony Howell, Tommy� Fornander, John D. Hainsworth, Robert E. Coleman, J. Vinholes, Manuel Modiano, Tamás Pintér, Shou Ching Tang, Bruce Colwell, Catherine Prady, Louise Provencher, David Walde, Álvaro Rodríguez-Lescure, Judith Hugh, Camille Loret, Matthieu Rupin, Sandra Blitz, Philip Jacobs, M Murawsky, A. Riva, Charles L. Vogel
Publicerad 2005Artigo -
12
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group av Matti Aapro, F.H. van Wijk, Giorgio Bolis, B Chevallier, M.E.L. van der Burg, Andrés Poveda, C F de Oliveira, Salvatore Tumolo, Vincenzo Scotto di Palumbo, Martine Piccart, Massimo Piergiuseppe Franchi, Flavia Zanaboni, Ángel J. Lacave, Rosanna Fontanelli, G. Favalli, Paolo Zola, Jean‐Paul Guastalla, Raffaella Rosso, Christian Marth, M. Nooij, M. Presti, C Scarabelli, Ted A.W. Splinter, E Ploch, L.V.A.M. Beex, W ten Bokkel Huinink, M. Forni, Mauro Melpignano, Peter Blake, Pierre Kerbrat, C. Mendiola, Andrés Cervantes, A Goupil, Peter Harper, C. Madroñal, M. Namer, Giovanna Scarfone, J.E.G.M. Stoot, Ivana Teodorović, Corneel Coens, Ignace Vergote, Jan B. Vermorken
Publicerad 2003Artigo -
13
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC... av Andreas du Bois, Michael Quinn, Tate Thigpen, Jan B. Vermorken, E. Åvall‐Lundqvist, Michael A. Bookman, David D.L. Bowtell, Mark F. Brady, Antonio Casado, Andrés Cervantes, E. A. Eisenhauer, Mitchell H. Friedlaender, Keiichi Fujiwara, Seija Grénman, Jean‐Paul Guastalla, P. Harper, Thomas Högberg, Stan B. Kaye, Henry C Kitchener, Gunnar B. Kristensen, Robert S. Mannel, Werner Meier, Brigitte Miller, J.P. Neijt, Amit M. Oza, Robert F. Ozols, Mahesh Parmar, S. Pecorelli, Jacobus Pfisterer, A. Poveda, Diane Provencher, Éric Pujade-Lauraine, Marcus E. Randall, Justine Rochon, G.J.S. Rustin, Satoru Sagae, Frederick B. Stehman, Gavin Stuart, Edward L. Trimble, P. Vasey, Ignace Vergote, René H.M. Verheijen, Uwe Wagner
Publicerad 2005Artigo
Sökverktyg:
Relaterade ämnen
Cancer
Internal medicine
Medicine
Oncology
Breast cancer
Chemotherapy
Surgery
Cisplatin
Gastroenterology
Metastatic breast cancer
Docetaxel
Neutropenia
Ovarian cancer
Paclitaxel
Adverse effect
Anthracycline
Biology
Carboplatin
Colorectal cancer
Nausea
Pathology
Pharmacology
Toxicity
Trastuzumab
Active metabolite
Adjuvant
Bevacizumab
Biochemistry
Capecitabine
Chromosome